百济神州(06160)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

06160 百济神州

休市中 06-18 16:08:08

163.700

+6.300

+4.00%

最高165.200	最低157.000	成交量612.93万
今开157.400	昨收157.400	日振幅5.21%
总市值2,523亿	流通市值2,334亿	总股本15.41亿
成交额9.97亿	换手率0.43%	流通股本14.26亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"06160","market":"HK","secType":"STK","nameCN":"百济神州","latestPrice":163.7,"timestamp":1781770088008,"preClose":157.4,"halted":0,"volume":6129278,"delay":0,"changeRate":0.0400254129606098,"floatShares":1426000000,"shares":1541000000,"eps":1.4887598630340928,"marketStatus":"休市中","change":6.3,"latestTime":"06-18 16:08:08","open":157.4,"high":165.2,"low":157,"amount":996741346,"amplitude":0.052097,"askPrice":163.7,"askSize":43400,"bidPrice":163.3,"bidSize":55000,"shortable":3,"etf":0,"ttmEps":2.6545215204155994,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1782091800000},"marketStatusCode":7,"adr":0,"listingDate":1533657600000,"exchange":"SEHK","adjPreClose":157.4,"openAndCloseTimeList":[[1781746200000,1781755200000],[1781758800000,1781769600000]],"volumeRatio":1.5518272880405877,"lotSize":100,"spreadScale":0,"tradeCurrency":"HKD","optionSymbol":"BOM.HK","astockBrief":{"symbol":"688235","market":"SH","secType":"STK","nameCN":"百济神州","latestPrice":218.22,"timestamp":1781766000000,"preClose":211.72,"halted":0,"volume":5470200,"delay":0,"premium":"-35.03"},"impliedVol":0.385,"impliedVolPercentile":0.2673},"requestUrl":"/m/hq/s/06160/tweets","defaultTab":"tweets","newsList":[{"id":"2644108640","title":"百济神州(06160)：授出购股权、受限制股份单位及业绩股份单位","url":"https://stock-news.laohu8.com/highlight/detail?id=2644108640","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2644108640?lang=zh_cn&edition=full","pubTime":"2026-06-18 21:11","pubTimestamp":1781788297,"startTime":"0","endTime":"0","summary":"于2026年6月11日，董事会、薪酬委员会及╱或首席执行官按照授权根据2016期权及激励计划的条款向8555名承授人授予合共1,499,134股美国存托股份受限制股份单位，并向32名承授人授予于完成目标100%时合共161,039股美国存托股份业绩股份单位。该等受限制股份单位及业绩股份单位合共相当于21,582,249股股份，约占本公告之日公司发行股份总数的1.4%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1456434.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU1719994722.HKD","LU0307460666.USD","BK1500","ONC","688235","BK1588","BK1583","BK4588","BK4585","LU1770034418.SGD","LU1251922891.USD","LU1969619763.USD","06160","LU0588546209.SGD","LU2328871848.SGD","BK4139","LU1303224171.USD","BK4526","BK1161","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644314776","title":"创新药概念普涨 再鼎医药(09688)升逾6% 机构指该板块仍将为行业核心增量","url":"https://stock-news.laohu8.com/highlight/detail?id=2644314776","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2644314776?lang=zh_cn&edition=full","pubTime":"2026-06-18 10:21","pubTimestamp":1781749308,"startTime":"0","endTime":"0","summary":"金吾财讯 | 港股创新药概念普涨，截至发稿，再鼎医药 涨6.34%，康方生物涨5.96%，药明康德涨3.59%，康诺亚-B涨3.49%，亚盛医药涨3.45%，药明生物涨3.08%，金斯瑞生物科技涨2.93%，百济神州涨2.60%。华鑫证券研究称，自2015年创新药审批改革开始，创新药逐步成为医药行业的核心增量。6月份以来，已有药明康德等企业开始公告回购或增持方案，逐步扭转市场对医药行业的信心。","market":"sg","thumbnail":"https://static.szfiu.com/news/20241108/MGQ5MWNhYjgxMjA0ZDU3OGI4Y2EzYTk1OWIyNGM1NTg2NTUyNjEzMTk5Ng==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/MGQ5MWNhYjgxMjA0ZDU3OGI4Y2EzYTk1OWIyNGM1NTg2NTUyNjEzMTk5Ng==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"84bb90b0e003ec2bc59dc9b9cb81d467","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1984066","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06978","06855","BK1161","LU0588546209.SGD","LU2328871848.SGD","LU2476274308.USD","BK1588","LU1719994722.HKD","02269","01548","BK1587","BK1589","LU0140636845.USD","SG9999002463.SGD","LU0979878070.USD","06160","02162","HK0000306685.HKD","LU0516423174.USD","BK1141","HK0000320223.HKD","BK4531","LU0417516571.SGD","09688","HK0000306701.USD","BK4526","LU2242644610.SGD","ZLAB","LU1720050803.USD","09926","LU1303224171.USD","LU0326950275.SGD","LU0516422366.SGD","02359","LU2488822045.USD","BK1521","LU0456846285.SGD","LU1794554557.SGD","LU1969619763.USD","BK1583","LU0561508036.HKD","IE00BPRC5H50.USD","159992","LU0307460666.USD","LU0348827113.USD","LU0516423091.SGD","LU0348784397.USD","LU2045819591.USD","LU0516422952.EUR","LU1961090484.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1160756131","title":"异动解读｜百济神州盘中上涨3.05%，百泽安食管鳞癌适应症获FDA受理叠加板块回暖","url":"https://stock-news.laohu8.com/highlight/detail?id=1160756131","media":"行情直击","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1160756131?lang=zh_cn&edition=full","pubTime":"2026-06-18 10:14","pubTimestamp":1781748850,"startTime":"0","endTime":"0","summary":"6月18日，百济神州盘中上涨3.05%，报162.3港元/股，成交额1.39亿港元。消息面上，百济神州近日公告百泽安针对食管鳞状细胞癌的新药上市申请获美国FDA受理，标志着公司核心产品在海外适应症拓展取得关键进展。此外，公司一季度归母净利润同比增长1801.3%，毛利率逼近90%，基本面持续改善。今日生物科技板块整体回暖，康方生物涨5.84%、科伦博泰生物涨3.72%、信达生物涨2.34%，板块联动效应对百济神州形成支撑。（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06160"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644773208","title":"【券商聚焦】中信建投：生物制品板块跟随医药行业整体回调 考虑与资金因素有关","url":"https://stock-news.laohu8.com/highlight/detail?id=2644773208","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2644773208?lang=zh_cn&edition=full","pubTime":"2026-06-18 09:26","pubTimestamp":1781745972,"startTime":"0","endTime":"0","summary":"金吾财讯 | 中信建投证券研究认为：1）中药：板块本周跑赢大盘及医药指数。市场关注呼吸道疾病发病率、基药目录等进展；除此市场持续关注“四同药品”价格专项治理、中成药集采等外部政策环境变化等带来的影响。2）生物制品：板块本周跑输医药指数及大盘。本周板块跟随医药行业整体回调，考虑主要与资金因素有关。3）医药商业：板块本周跑输申万医药，跑赢大盘。药店板块主要关注5月同店数据；流通板块关注院内合规及红利标的。","market":"fut","thumbnail":"https://static.szfiu.com/news/20250109/MjZhZmU5OWE5M2M5YjFiNzE1NDI2Mjg5NzQxNQ==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250109/MjZhZmU5OWE5M2M5YjFiNzE1NDI2Mjg5NzQxNQ==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1984059","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1207","BK1500","LU0348766576.USD","02196","601066","LU0588546209.SGD","BK1585","LU0348767384.USD","LU2476274720.SGD","LU0348735423.USD","LU0417516571.SGD","LU0417516902.SGD","LU0540923850.HKD","LU1969619763.USD","BK1100","BK1191","BK1515","IE00B3M56506.USD","01789","02228","09688","IE00BPRC5H50.USD","SG9999004311.SGD","LU0561508036.HKD","BK1161","03933","01099","02268","LU0348784397.USD","LU0348827113.USD","06821","02367","LU2328871848.SGD","LU2476274308.USD","LU1720050803.USD","LU1303224171.USD","BK1588","LU2399975544.HKD","LU1719994722.HKD","IE00B5MMRT66.SGD","BK1574","BK1141","BK1197","LU0640798160.USD","SG9999014674.SGD","06160","01530","LU1770034418.SGD","09926","LU0348783233.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643822932","title":"【券商聚焦】交银国际：医药行业上半年表现整体稳健 下半年内部分化或加大","url":"https://stock-news.laohu8.com/highlight/detail?id=2643822932","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2643822932?lang=zh_cn&edition=full","pubTime":"2026-06-15 10:21","pubTimestamp":1781490116,"startTime":"0","endTime":"0","summary":"金吾财讯 | 交银国际研报指，医药行业在1H26表现整体稳健、但内部分化也较为明显。短期关注出海交易、业绩表现和利好政策落地。推荐高景气度赛道中、投资性价比较高的头部玩家，包括药明合联、凯莱英和康龙化成。2026年港股龙头收入和净利润增速有望稳定在双位数。板块复苏积极信号已经出现。","market":"nz","thumbnail":"https://static.szfiu.com/news/20250109/NjBmYTFlMmI3YzYzNjVkMWZlODgyMTcwNTE1Njk3NDY=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250109/NjBmYTFlMmI3YzYzNjVkMWZlODgyMTcwNTE1Njk3NDY=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1983754","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BZ08YR35.GBP","09926","06821","01093","LU0502904849.HKD","01530","06990","01952","LU3063872942.SGD","LU0819121731.USD","LU2097828631.EUR","LU0051755006.USD","LU0348827113.USD","01951","02273","IE00B0JY6N72.USD","LU1226287875.USD","02269","LU1688375341.USD","03692","09996","00013","03329","01177","01801","02162","LU2399975544.HKD","02596","01548","02268","02096","09966","LU0320764599.SGD","LU0181495838.USD","HK0000306685.HKD","06160","06078","LU1960683339.HKD","03759","LU0737861772.HKD","01276","LU1242518857.USD","06996","LU1880383366.USD","BK1191","HK0000320264.USD","BK1576","LU0456827905.SGD","SG9999002562.SGD","LU0140636845.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1126927102","title":"异动解读｜百济神州盘中下跌4.17%，高层减持叠加创新药板块持续承压","url":"https://stock-news.laohu8.com/highlight/detail?id=1126927102","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1126927102?lang=zh_cn&edition=full","pubTime":"2026-06-11 09:36","pubTimestamp":1781141769,"startTime":"0","endTime":"0","summary":"6月11日，百济神州盘中下跌4.17%，报159.2港元/股，成交额7442.1万港元。消息面上，百济神州近期遭遇贝克兄弟关联基金Baker Bros. Advisors LP大幅减持约1.9亿美元，虽其仍保留董事会席位且合计持股约8.21%，但减持动作持续压制市场情绪。此外，多位董事于近期小幅减持股份，进一步加重抛压预期。南向资金近20个交易日中有17天净减持，累计净减持超1041万股。今日生物科技板块整体偏弱，康方生物跌2.67%、三生制药跌1.76%，百济神州作为权重龙头持续受到拖累。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06160"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642947706","title":"港股开盘受压 恒指低开0.11% 洛阳钼业(03993)跌4.30%","url":"https://stock-news.laohu8.com/highlight/detail?id=2642947706","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2642947706?lang=zh_cn&edition=full","pubTime":"2026-06-11 09:28","pubTimestamp":1781141311,"startTime":"0","endTime":"0","summary":"金吾财讯 | 港股开盘受压，恒指低开0.11%，国企指数低开0.07%，恒生科技指数低开0.2%。洛阳钼业跌4.30%，紫金矿业跌2.56%，信义玻璃跌2.02%，百济神州跌1.96%，华润万象生活跌1.72%。美元走势向上，美国十年期债息上升至4.56厘水平，金价大幅回落，油价则表现向好。内地股市昨日下跌，沪综指低开低走，收市下跌0.4%，沪深两市成交额亦略为增加。港股表现持续乏力，指数低开后跌幅一度扩大，尾市跌势略为回顺，整体成交保持活跃。","market":"nz","thumbnail":"https://static.szfiu.com/news/20210810/NGVhNjVkZTQ2ODU4ZWQyYjc4YjcyMmRkNWUzMjAzNTczNzI1NTIy.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20210810/NGVhNjVkZTQ2ODU4ZWQyYjc4YjcyMmRkNWUzMjAzNTczNzI1NTIy.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1983521","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0577902454.USD","BK1502","83115","BK1594","IE00BZ08YS42.EUR","LU2271345857.HKD","00883","HK0000320223.HKD","LU1769817096.USD","LU1439103000.SGD","LU0140636845.USD","LU2097828805.USD","03032","LU1119993845.HKD","LU1568876251.USD","IE00B5TLWC47.USD","LU2328871848.SGD","HK0000288743.USD","LU1960683339.HKD","HK0000288784.HKD","IE00B031J352.USD","LU0588545730.USD","LU0307460666.USD","IE0004086264.USD","03417","LU1969619763.USD","LU1242518857.USD","BK1505","SG9999000459.SGD","BK1226","BK1184","LU0326950275.SGD","LU0293314216.USD","LU0228659784.USD","SGXZ62798434.SGD","LU0819123356.HKD","02833","81024","LU1804176565.USD","LU1956131251.USD","LU0289739343.SGD","LU1880383440.USD","SG9999014005.SGD","LU0329678170.USD","LU0463099449.HKD","LU0106959298.USD","HK0000151867.HKD","LU1642822792.SGD","LU0048388663.USD","LU1363072403.SGD","GB00BDT5M118.USD","IE0008368742.USD","IE00BZ08YR35.GBP","LU0164865239.USD","LU0955669360.SGD","BK1500","HK0000306701.USD","LU0672654166.SGD","LU1102505929.USD","IE00BWDBJ730.SGD","00175","LU0192582467.USD","BK1544","LU0918141887.USD","LU0823397103.USD","LU0039217434.USD","LU0289961442.SGD","LU1813983027.USD","LU2023251221.USD","IE00B97KM107.HKD","LU0738912210.USD","LU0287142896.SGD","LU1785774172.SGD","688235","IE0004091025.USD","LU1712237335.SGD","LU2089284900.SGD","LU0359201885.HKD","LU1481012133.USD","LU0886674414.USD","LU1328277881.USD","LU1623119135.USD","02477","LU0269904917.USD","LU0516423174.USD","LU0541502299.USD","IE00B031HW06.USD","LU1196710864.SGD","LU0577902611.USD","LU0051755006.USD","LU2226246903.HKD","LU0577902298.EUR","KSTmain","LU2265009873.SGD","81299","LU0370786039.SGD","LU0607220059.USD","09067","LU0128522157.USD","LU0708995583.HKD","LU0359201612.USD","LU0831103253.SGD","LU0048597586.USD","LU0509642566.USD","LU0164939612.USD","LU2111349929.HKD","LU0163747925.USD","LU0414403682.SGD","LU1044874839.SGD","LU2087589342.USD","LU0069063385.USD","BK1095","LU2097828714.EUR","LU1993786604.SGD","LU0823426308.USD","LU1831875114.USD","LU0320764599.SGD","LU1961090484.USD","LU0096374516.USD","LU0890818403.SGD","02800","LU0516423091.SGD","603993","LU0348788117.USD","LU0823038988.USD","LU1770034418.SGD","80175","HK0000320264.USD","LU1497733557.USD","LU0348767384.USD","LU0082770016.USD","LU0985320562.USD","LU1328615791.USD","LU0359202008.SGD","LU2045819591.USD","LU0244354667.USD","LU1400636657.SGD","LU0878005551.USD","LU0326948709.USD","LU0396098781.USD","IE00B3T34201.USD","LU2148510915.USD","LU0431992006.USD","LU1152091754.HKD","LU1064131342.USD","LU0417516738.SGD","BK1539","SG9999001846.SGD","LU1282651121.HKD","ONC","LU0084288322.USD","LU0132412106.USD","LU0630378429.USD","LU1981816686.USD","SG9999000327.SGD","LU2097828557.USD","LU2213484517.USD","LU0228367735.SGD","LU1102505762.USD","IE00BYQQ9H92.USD","LU1988902786.USD","LU2152927971.USD","LU2153592121.USD","LU1497734951.SGD","LU0877626530.USD","IE0032834883.USD","01209","LU0831093199.SGD","LU1202635105.USD","SGXZ86797644.SGD","LU0762541174.USD","600938","LU1634259391.SGD","LU0328353924.USD","LU0441854154.USD","LU1807302812.USD","LU0210527791.USD","SG9999006597.SGD","BK1608","LU2348773727.SGD","03067","BK1161","BK1224","EVS.SI","LU0417516902.SGD","LU0640798160.USD","IE0032431581.USD","82800","BK1591","LU1983260115.SGD","LU1629966141.USD","LU0762542818.HKD","LU1048484197.HKD","SG9999001903.USD","03419","LU0594300179.USD","LU0348766576.USD","LU0871576103.HKD","LU0106252389.USD","LU1224444064.USD","LU1115378108.SGD","80883","601857","LU0314109678.HKD","03423","LU0169518387.USD","LU0211977185.USD","BK1105","LU0516422440.USD","LU3063872942.SGD","LU0266512127.USD","LU0577902371.SGD","LU0043850808.USD","SG9999014674.SGD","LU0067412154.USD","LU2089283258.USD","LU0251143458.SGD","LU0456846285.SGD","LU2187417386.USD","BK1592","LU0266013472.USD","02899","LU0821914370.USD","SGXZ23171101.USD","LU2348774022.SGD","LU1023057109.AUD","LU1323998911.USD","LU0405327494.USD","LU0784639295.USD","LU1645745479.HKD","01024","LU0918141705.HKD","LU0149534421.HKD","LU0057025933.USD","LU1044876610.USD","LU0605514214.HKD","LU1719994722.HKD","IE0003795394.USD","IE00B0JY6N72.USD","LU0106259558.USD","IE00BQJZWZ67.USD","IE00BZ08YT58.USD","LU0823039010.USD","03037","LU0082770016.SGD","02837","LU0181495838.USD","LU0540923850.HKD","LU0819121731.USD","LU0261950983.USD","LU1770036033.HKD","SG9999014013.SGD","LU0348735423.USD","LU0561508036.HKD","LU0348805143.USD","LU0417516571.SGD","513600","LU0345780281.USD","01299","LU0620787316.HKD","LU1439102457.SGD","00857","LU0327786744.USD","LU0469268626.HKD","IE00BF5LJ272.USD","SG9999001093.SGD","03088","LU1400636491.USD","BK1190","LU0011963245.USD","LU0315179316.USD","LU0630378692.HKD","LU1522347837.USD","LU0061477393.USD","LU0348827113.USD","LU0511384066.AUD","LU0315178854.USD","LU1794554557.SGD","LU2177674079.SGD","LU1188198961.HKD","LU0611395673.USD","IE00B0169L03.USD","LU1808992512.USD","LU0049853897.USD","LU0261950470.USD","HSI","ZIJMY","07552","LU0516422952.EUR","LU0880133367.SGD","LU1251922891.USD","BK1258","LU1400636574.HKD","IE0008369823.USD","LU1008478684.HKD","LU0029875118.USD","LU0979878070.USD","BK1590","LU0345776255.USD","BK1198","LU2257852520.SGD","SG9999001689.USD","LU1282651048.USD","LU0197773673.USD","XYIGY","09088","LU0737861772.HKD","SG9999004220.SGD","LU0456854461.SGD","LU1242518931.SGD","LU0345775950.USD","LU0196878994.USD","LU0823426480.USD","00590","BK1583","LU0158827781.USD","LU1675838814.USD","IE0003851619.USD","LU2929501877.USD","LU0577902538.SGD","03993","LU0197773160.USD","BK1155","BK1610","LU0266512473.USD","LU0348825331.USD","LU0188438112.USD","BK1554","LU0862451753.SGD","LU1880383366.USD","LU0828237510.HKD","07300","BK1589","LU0634319403.HKD","LU0320764755.SGD","LU0348814723.USD","LU0572939691.SGD","LU1688375341.USD","BK1238","LU0345780521.USD","LU1734074674.USD","HHImain","IE00B8L5B284.USD","LU0264606111.USD","LU0593848301.USD","IE0008368411.USD","LU0048580855.USD","SG9999002463.SGD","LU0737861699.HKD","LU1130305938.SGD","LU0149721374.USD","LU2008162690.USD","LU2449936058.SGD","07226","SG9999003461.SGD","LU1048596156.SGD","LU0251144936.SGD","LU0348784397.USD","LU0856984785.SGD","LU1303224171.USD","LU0501845795.SGD","LU1861214812.USD","LU2293587155.HKD","LU1481107354.HKD","LU1224709979.USD","LU1769817179.HKD","LU0235996351.USD","601899","BK1588","LU0541501648.USD","LU0348783662.USD","LU0543330483.HKD","LU2153591404.USD","IE0009570106.USD","IE00BFXG0V08.USD","LU0762540952.USD","LU0588546209.SGD","BK1545","LU1720050803.USD","LU0456827905.SGD","LU0572944931.SGD","LU0329678337.USD","BK1575","LU1497733631.SGD","LU0348783233.USD","LU1044875133.USD","LU1152091168.USD","LU0828237940.HKD","LU2264538146.SGD","LU0955623706.USD","09115","LU1048588211.SGD","LU0873338254.USD","LU1670756490.USD","SG9999004311.SGD","HSTECH","LU2125910500.SGD","MCHmain","SG9999002828.SGD","IE00B8HQ1Z84.USD","LU0878004406.USD","LU1821325948.USD","LU0650527681.SGD","LU0572940350.SGD","LU0797268264.HKD","03033","LU0972618739.USD","LU0205439572.USD","BK1615","LU2097828631.EUR","LU0054237671.USD","LU0173614495.USD","LU0955648018.USD","SG9999002562.SGD","IE00B067MR52.USD","SG9999014021.USD","00868","BK1119","LU0882747503.HKD","BK1229","LU1634259557.SGD","LU0588545904.SGD","IE00B031HY20.USD","LU0405327148.USD","LU0588545490.SGD","IE0031814852.USD","LU0557290698.USD","LU1504937902.USD","LU0675040207.SGD","AAGIY","LU0158827948.USD","LU0516422366.SGD","LU0823397285.USD","LU0164880469.USD","LU1064131003.USD","LU2351347302.SGD","BK1542","SG9999014039.USD","IE00B19Z5X02.USD","LU2028103732.USD","LU2360107325.USD","LU0868486357.SGD","GELYY","LU0531971595.HKD","06160","LU0472753341.HKD","LU0048575426.USD","LU0456842615.SGD","LU1064130708.USD","LU0210526637.USD","LU0865486749.SGD","03115","LU2399975544.HKD","07500","LU0828238088.HKD","BK1528","IE00BKZH1Z71.USD","LU0117844026.USD","LU1568876335.HKD","LU1046422090.SGD","LU0594300419.USD","LU0348816934.USD","LU0072462343.USD","LU0072913022.USD","LU0862451837.USD","LU1105468828.SGD","SG9999004303.SGD","LU1861219969.SGD","LU2039709279.SGD","LU0261947096.USD","LU0052750758.USD","HK0000306685.HKD","LU0971096721.USD","LU0165289439.USD","LU0898667661.SGD","LU1282648689.USD","LU1655091459.SGD","LU2097828474.EUR","BK1601","BK1521","BK1602","07200"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1176178782","title":"异动解读｜百济神州盘中下跌3.13%，高层减持叠加创新药板块持续承压","url":"https://stock-news.laohu8.com/highlight/detail?id=1176178782","media":"行情直击","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1176178782?lang=zh_cn&edition=full","pubTime":"2026-06-09 10:57","pubTimestamp":1780973868,"startTime":"0","endTime":"0","summary":"6月9日，百济神州盘中下跌3.13%，报158.0港元/股，成交额2.86亿港元。消息面上，百济神州近期遭遇贝克兄弟关联基金Baker Bros. Advisors LP大幅减持约1.9亿美元，虽其仍保留董事会席位且合计持股约8.21%，但减持动作持续压制市场情绪。此外，多位董事于近期小幅减持股份，进一步加重抛压预期。港股创新药板块自去年9月调整至今已超8个月，板块标的指数区间跌幅超30%。今日生物科技板块整体走弱，康方生物跌3.47%、信达生物跌1.98%，百济神州作为权重龙头持续受到拖累。（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06160"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641122476","title":"每周股票复盘：百济神州（688235）股东Amgen持股比例被动稀释至16.70%","url":"https://stock-news.laohu8.com/highlight/detail?id=2641122476","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2641122476?lang=zh_cn&edition=full","pubTime":"2026-06-07 01:36","pubTimestamp":1780767371,"startTime":"0","endTime":"0","summary":"截至2026年6月5日收盘，百济神州报收于220.18元，较上周的243.9元下跌9.73%。本周，百济神州6月1日盘中最高价报248.88元。百济神州当前最新总市值3393.9亿元，在化学制药板块市值排名1/150，在两市A股市值排名40/5206。公司公告汇总百济神州有限公司持股5%以上股东Amgen Inc.因公司发行美国存托股份导致持股比例被动稀释，持股数量未变，仍为246,269,426股，持股比例由17.01%下降至16.70%，权益变动触及1%刻度。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060700000325.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["06160","LU1303224171.USD","BK1161","BK1588","LU1770034418.SGD","LU2328871848.SGD","688235","LU1969619763.USD","LU1719994722.HKD","LU0307460666.USD","BK1583","LU0588546209.SGD","LU1251922891.USD","BK0239","BK1500"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2641829119","title":"百济神州(06160)：授出受限制股份单位","url":"https://stock-news.laohu8.com/highlight/detail?id=2641829119","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2641829119?lang=zh_cn&edition=full","pubTime":"2026-06-05 17:12","pubTimestamp":1780650777,"startTime":"0","endTime":"0","summary":"智通财经APP讯，百济神州(06160)发布公告，于2026年6月1日，董事会薪酬委员会根据2016期权及激励计划的条款授予381名承授人合共42,648股美国存托股份受限制股份单位。该等受限制股份单位相当于554,424股股份，约占本公告之日公司发行股份总数的0.04%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1450730.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU1303224171.USD","LU2328871848.SGD","06160","BK4139","LU1251922891.USD","BK4588","LU1969619763.USD","ONC","LU0588546209.SGD","BK1500","LU1719994722.HKD","BK1161","BK4585","LU1770034418.SGD","BK1588","LU0307460666.USD","BK0239","BK4526","BK1583","688235"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1124035598","title":"异动解读｜百济神州盘中下跌3.1%，高层减持叠加创新药板块持续承压","url":"https://stock-news.laohu8.com/highlight/detail?id=1124035598","media":"行情直击","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1124035598?lang=zh_cn&edition=full","pubTime":"2026-06-05 13:34","pubTimestamp":1780637640,"startTime":"0","endTime":"0","summary":"6月5日，百济神州盘中下跌3.1%，报162.7港元/股，成交额5.42亿港元。消息面上，百济神州近期遭遇贝克兄弟关联基金Baker Bros. Advisors LP大幅减持约1.9亿美元，虽其仍保留董事会席位且合计持股约8.21%，但减持动作持续压制市场情绪。此外，港股创新药板块自去年9月调整至今已超8个月，板块标的指数区间跌幅超30%。今日生物科技板块整体走弱，康方生物跌3.92%、荣昌生物跌2.56%、三生制药跌1.81%，百济神州作为权重龙头持续受到拖累。（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06160"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1164340118","title":"百济神州5月无新增股份发行 股本维持稳定","url":"https://stock-news.laohu8.com/highlight/detail?id=1164340118","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1164340118?lang=zh_cn&edition=full","pubTime":"2026-06-04 17:41","pubTimestamp":1780566089,"startTime":"0","endTime":"0","summary":"百济神州公布截至2026年5月31日的证券变动月报。公告显示，公司于该月未有新增发行股份或购回、注销及库藏股变动，已发行普通股数目维持在1,426,363,848股。公司于上海证券交易所科创板上市的115,055,260股人民币股份亦无变动。公司董事会确认，截至报告期末，已符合香港联交所防止持股过度集中的相关规则。公司表示将持续关注并严格遵守香港联交所及其他监管机构的相关规定，确保股本稳定及规范运作。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06160"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1185489244","title":"异动解读｜百济神州盘中上涨4.18%，连续下跌后反弹叠加安泰适获批提振","url":"https://stock-news.laohu8.com/highlight/detail?id=1185489244","media":"行情直击","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1185489244?lang=zh_cn&edition=full","pubTime":"2026-06-04 09:39","pubTimestamp":1780537162,"startTime":"0","endTime":"0","summary":"6月4日，百济神州盘中上涨4.18%，报171.2港元/股，成交额1.23亿港元。该股此前连续三个交易日累计下跌约10%，主要受Baker Bros. Advisors LP减持约1.9亿美元及创新药板块持续调整拖累。利好方面，百济神州5月29日宣布安泰适（注射用塔拉妥单抗）获NMPA批准用于广泛期小细胞肺癌二线治疗，临床数据显示可降低死亡风险40%，中位总生存期延长5.3个月。今日生物科技板块整体企稳，前期超跌个股出现反弹。（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06160"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1153099751","title":"异动解读｜百济神州盘中下跌3.02%，高层减持叠加创新药板块持续承压","url":"https://stock-news.laohu8.com/highlight/detail?id=1153099751","media":"行情直击","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1153099751?lang=zh_cn&edition=full","pubTime":"2026-06-03 10:37","pubTimestamp":1780454277,"startTime":"0","endTime":"0","summary":"6月3日，百济神州盘中下跌3.02%，报163.7港元/股，成交额2.9亿港元。消息面上，百济神州近期遭遇贝克兄弟关联基金Baker Bros. Advisors LP大幅减持约1.9亿美元，虽其仍保留董事会席位且合计持股约8.21%，但减持动作持续压制市场情绪。此外，港股创新药板块自去年9月调整至今已超8个月，板块标的指数区间跌幅超30%。今日生物科技板块整体走弱，康方生物跌4.6%、科伦博泰生物跌4.21%、三生制药跌3.32%，百济神州作为权重龙头持续受到拖累。（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06160"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640915411","title":"6月2日百济神州跌5.88%，万家行业优选LOF基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2640915411","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2640915411?lang=zh_cn&edition=full","pubTime":"2026-06-02 16:32","pubTimestamp":1780389170,"startTime":"0","endTime":"0","summary":"证券之星消息，6月2日百济神州跌5.88%，收盘报220.82元，换手率4.99%，成交量5.75万手，成交额12.79亿元。根据2026基金Q1季报公募基金重仓股数据，重仓该股的公募基金共107家，其中持有数量最多的公募基金为万家基金的万家行业优选LOF。万家行业优选LOF的前十大重仓股如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060200030885.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["06160","BK1583","LU0588546209.SGD","BK0239","LU1969619763.USD","LU2328871848.SGD","LU1719994722.HKD","160916","BK1588","LU0307460666.USD","LU1251922891.USD","LU1303224171.USD","LU1770034418.SGD","BK1161","688235","BK1500"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640915197","title":"百济神州跌5.88%，浦银国际证券二个月前给出“买入”评级，目标价236.00元","url":"https://stock-news.laohu8.com/highlight/detail?id=2640915197","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2640915197?lang=zh_cn&edition=full","pubTime":"2026-06-02 16:32","pubTimestamp":1780389156,"startTime":"0","endTime":"0","summary":"今日百济神州跌5.88%，收盘报220.82元。2026年3月9日，浦银国际证券研究员阳景,胡泽宇发布了对百济神州的研报《四季度收入符合预期，2026年催化剂丰富》，该研报对百济神州给出“买入”评级，认为其目标价为236.0元，研报发布时股价为238.49元，预期涨幅为1.04%。此外，东吴证券研究员朱国广，中邮证券研究员盛丽华,陈灿近期也对该股发布了研报，同样给出“买入”评级。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060200030880.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688235","06160","161027"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1106508512","title":"异动解读｜百济神州盘中下跌3.85%，高层减持叠加创新药板块持续承压","url":"https://stock-news.laohu8.com/highlight/detail?id=1106508512","media":"行情直击","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1106508512?lang=zh_cn&edition=full","pubTime":"2026-06-02 09:52","pubTimestamp":1780365134,"startTime":"0","endTime":"0","summary":"6月2日，百济神州盘中下跌3.85%，报165.8港元/股，成交额2.17亿港元。消息面上，百济神州近期遭遇贝克兄弟关联基金Baker Bros. Advisors LP大幅减持约1.9亿美元，虽其仍保留董事会席位且合计持股约8.21%，但减持动作持续压制市场情绪。此外，港股创新药板块自去年9月调整至今已超8个月，板块标的指数区间跌幅超30%。今日生物科技板块整体走弱，康方生物跌4.57%、三生制药跌7.78%、信达生物跌4.2%，百济神州作为权重龙头持续受到拖累。（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06160"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640957252","title":"百济神州（688235）披露持股5%以上股东权益变动触及1%刻度的提示性公告，6月1日股价下跌3.8%","url":"https://stock-news.laohu8.com/highlight/detail?id=2640957252","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2640957252?lang=zh_cn&edition=full","pubTime":"2026-06-01 22:05","pubTimestamp":1780322737,"startTime":"0","endTime":"0","summary":"截至2026年6月1日收盘，百济神州报收于234.62元，较前一交易日下跌3.8%，最新总市值为3616.48亿元。该股当日开盘241.3元，最高248.88元，最低233.3元，成交额达12.42亿元，换手率为4.49%。近日，百济神州有限公司发布《关于持股5%以上股东权益变动触及1%刻度的提示性公告》。公告显示，公司持股5%以上股东Amgen Inc.因公司发行美国存托股份导致持股比例被动稀释，持股数量未变，仍为246,269,426股，持股比例由17.01%下降至16.70%，权益变动触及1%刻度。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060100040484.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1588","LU1719994722.HKD","LU0588546209.SGD","LU1770034418.SGD","LU1251922891.USD","LU1969619763.USD","BK1500","LU2328871848.SGD","688235","LU1303224171.USD","LU0307460666.USD","BK1161","BK1583","06160","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1198958973","title":"异动解读｜百济神州盘中下跌3.11%，高层减持叠加创新药板块持续调整","url":"https://stock-news.laohu8.com/highlight/detail?id=1198958973","media":"行情直击","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1198958973?lang=zh_cn&edition=full","pubTime":"2026-06-01 11:11","pubTimestamp":1780283507,"startTime":"0","endTime":"0","summary":"6月1日，百济神州盘中下跌3.11%，报171.3港元/股，成交额3.57亿港元。消息面上，百济神州近期遭遇高层大额减持，贝克兄弟关联基金Baker Bros. Advisors LP减持约1.9亿美元，市场情绪承压。尽管机构仍保留董事会席位且合计持股比例约8.21%，但减持动作引发资金面担忧。此外，港股创新药板块自去年9月进入调整期至今已超8个月，板块标的指数区间跌幅超过30%，百济神州作为权重龙头持续受到拖累。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06160"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639644366","title":"百济神州安泰适在华获批用于小细胞肺癌二线治疗","url":"https://stock-news.laohu8.com/highlight/detail?id=2639644366","media":"南方财经网","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2639644366?lang=zh_cn&edition=full","pubTime":"2026-05-29 14:18","pubTimestamp":1780035480,"startTime":"0","endTime":"0","summary":"南方财经5月29日电，百济神州宣布，安泰适?（注射用塔拉妥单抗）获得国家药品监督管理局（NMPA）新增适应症批准，用于既往接受过1种系统性治疗（包括含铂化疗）失败的广泛期小细胞肺癌（ES-SCLC）成人患者。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202605293754345695.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU0588546209.SGD","LU1969619763.USD","BK0239","BK4526","BK1500","06160","BK1583","LU1719994722.HKD","LU2328871848.SGD","BK4139","BK1161","688235","LU1770034418.SGD","LU1251922891.USD","ONC","LU1303224171.USD","BK4585","BK1588","LU0307460666.USD","BK4588"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.beonemedicines.com","stockEarnings":[{"period":"1week","weight":0.0534},{"period":"1month","weight":-0.0635},{"period":"3month","weight":-0.0314},{"period":"6month","weight":-0.1156},{"period":"1year","weight":0.0589},{"period":"ytd","weight":-0.087}],"compareEarnings":[{"period":"1week","weight":-0.0134},{"period":"1month","weight":-0.0726},{"period":"3month","weight":-0.0535},{"period":"6month","weight":-0.0687},{"period":"1year","weight":0.009},{"period":"ytd","weight":-0.0666}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"BeOne Medicines AG（原名：BeiGene Ltd）是一家全球肿瘤学公司，致力于为全球癌症患者研发新疗法。该公司产品组合涵盖血液学和实体瘤，致力于开发多样化的新型疗法。其产品包Brukinsa、Tevimbra和Pamiparib。Brukinsa是一种口服的布鲁顿酪氨酸激酶(BTK)小分子抑制剂。Tevimbra是一种人源化免疫球蛋白G4（IgG4）抗程序性细胞死亡蛋白1（PD-1）单克隆抗体，具有高亲和力和对PD-1的结合特异性。Tevimbra旨在最大限度地减少与巨噬细胞上Fc-γ（Fcy）受体的结合，帮助人体免疫细胞检测和对抗肿瘤。该公司正在开发的产品线包括Sonrotoclax、Tarlatamab、Zanidatamab、Blinatumomab、BGB-26808、BGB-R046、BG-68501、BG-C9074、BGB-43395、Xaluritamig等。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.027621},{"month":2,"riseRate":0.5,"avgChangeRate":0.032126},{"month":3,"riseRate":0.125,"avgChangeRate":-0.059409},{"month":4,"riseRate":0.5,"avgChangeRate":0.034277},{"month":5,"riseRate":0.375,"avgChangeRate":-0.043816},{"month":6,"riseRate":0.375,"avgChangeRate":-0.003113},{"month":7,"riseRate":0.857143,"avgChangeRate":0.097108},{"month":8,"riseRate":0.857143,"avgChangeRate":0.058603},{"month":9,"riseRate":0.5,"avgChangeRate":0.025162},{"month":10,"riseRate":0.5,"avgChangeRate":-0.027038},{"month":11,"riseRate":0.625,"avgChangeRate":0.118183},{"month":12,"riseRate":0.125,"avgChangeRate":-0.07577}],"exchange":"SEHK","name":"百济神州","nameEN":"BEIGENE"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.0","shortVersion":"4.44.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"百济神州(06160)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供百济神州(06160)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"百济神州,06160,百济神州股票,百济神州股票老虎,百济神州股票老虎国际,百济神州行情,百济神州股票行情,百济神州股价,百济神州股市,百济神州股票价格,百济神州股票交易,百济神州股票购买,百济神州股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"百济神州(06160)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供百济神州(06160)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}